Clinical Trial

PATH-03 Paraguay Feasibility Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to evaluate the safety and effectiveness of the ePATH system in the creation of an endovascular AVF (endoAVF) in patients who require or will soon require hemodialysis and are eligible for a fistula.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-13.
Trial Details
NCT Number NCT07034092
Lead Sponsor Pathfinder Medical
Collaborators: MINSA SA
Conditions Kidney Disease, End-Stage
Enrollment 20 participants
Start Date 2025-10
Primary Completion 2026-06 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-07-17